scispace - formally typeset
J

Jun Sugawara

Researcher at National Institute of Advanced Industrial Science and Technology

Publications -  151
Citations -  6106

Jun Sugawara is an academic researcher from National Institute of Advanced Industrial Science and Technology. The author has contributed to research in topics: Blood pressure & Arterial stiffness. The author has an hindex of 36, co-authored 135 publications receiving 5447 citations. Previous affiliations of Jun Sugawara include University of Texas Southwestern Medical Center & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness.

TL;DR: It is indicated that cfPWV and baPWVs are indices of arterial stiffness that exhibit similar extent of associations with cardiovascular disease risk factors and clinical events.
Journal ArticleDOI

Unfavorable Effects of Resistance Training on Central Arterial Compliance A Randomized Intervention Study

TL;DR: In marked contrast to the beneficial effect of regular aerobic exercise, several months of resistance training “reduces” central arterial compliance in healthy men.
Journal ArticleDOI

Brachial–ankle pulse wave velocity: an index of central arterial stiffness?

TL;DR: Brachial–ankle pulse wave velocity may provide qualitatively similar information to those derived from central arterial stiffness although some portions of baPWV may be determined by peripheral arterials stiffness.
Journal ArticleDOI

Age-Associated Elongation of the Ascending Aorta in Adults

TL;DR: The aorta lengthens with age, even in healthy humans, due primarily to the elongation of the ascending aorte, which undergoes lengthening with age and is not included in the arterial length measurements.
Journal ArticleDOI

Effects of exercise training of 8 weeks and detraining on plasma levels of endothelium-derived factors, endothelin-1 and nitric oxide, in healthy young humans.

TL;DR: It is suggested that chronic exercise causes an increase in production of NO and a decrease inProduction of ET-1 in humans, which may produce beneficial effects (i.e., vasodilative and antiatherosclerotic) on the cardiovascular system.